公司資料
Idera 股價、新聞與催化劑
- 股票代碼:
- IDRA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for IDRA.
公司概覽
業務概覽
Idera Pharmaceuticals is a historical small-cap biotechnology name associated with immunology and oncology programs, including work around innate immune pathways. The company has long been a legacy example of a narrow pipeline trying to create value in a very competitive biotech market.
所在地與產業分類
Idera is headquartered in the United States and listed on NASDAQ, with a profile that has historically sat in small-cap biotech. It belongs more to the legacy development group than to a large commercial franchise.
商業模式特徵
The business model was defined by clinical development, capital preservation, and the ability to keep a focused pipeline alive long enough to generate value. Investors historically watched data updates, restructuring activity, and financing runway.
生技產業定位
Idera sits in the historical category of high-risk micro-cap biotech names. It is best understood as a legacy development story where execution and financing risk were always dominant.
未來催化劑
- Idera is now largely a legacy / closeout story, so the catalysts are any asset-resolution update rather than a live pipeline readout. The company is mainly in wind-down mode.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。